U.S. judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list
The ruling is a blow to compounding pharmacies that were allowed to produce doses of copies of obesity drugs while the FDA said there was a shortage.
You are not logged in so some information on this page has been withheld. To see more, please log in.